Portfolio company
Amgen
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops and manufactures biologic medicines to treat patients with serious illnesses, including cancer, kidney disease and inflammatory disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Amgen Europe
This company develops and manufactures biotechnological medicines to treat patients with serious conditions such as cancer, cardiovascular disease and inflammatory disorders.
Genentech
This biotechnology company develops and manufactures medicines for patients with serious diseases including cancer, multiple sclerosis, and respiratory conditions.
Biogen Idec
This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.
Regeneron
This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.
Amphista Therapeutics
This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
Coherus
This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
